Related Experiment Video
Updated: Mar 27, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Melamine Nephrotoxicity is Mediated by Hyperuricemia
Long Zhang1, Hong Tian Li2, Lin Lin Wang2
1Institute of Reproductive and Child Health/Ministry of Health Key Laboratory of Reproductive Health, Peking University Health Science Center, Beijing 100191, China; Department of Epidemiology and Health Statistics, School of Public Health, Peking University Health Science Center, Beijing 100191, China.
Objective:
We tested whether melamine nephrotoxicity was exacerbated by urate (a typical component of renal stones in humans) in rats with hyperuricemiainduced by the uricase inhibitor, potassium oxonate (Oxo).
Methods:
Rats were exposed to melamine or Oxo alone or combinations of melamine (200-400 mg/kg) and Oxo (200-600 mg/kg) for 3 consecutive days. Kidney injury was evaluated by renal biochemical functions, histomorphology, and lipid peroxidation. Kidney crystals were analyzed for their composition.
Results:
Nephrotoxicity was minimal in animals administered melamine or Oxo alone, but it was demonstrable in animals administered at least 800 mg/kg of the two compounds combined. All rats in the 400+600 (melamine+Oxo) and 400+400 mg/kg groups and 4 out of 6 in the 200+600 mg/kg group died within 3 days; no rat died in the 200+400 or 200+200 mg/kg group. Dose-dependent renal damage resembling clinical findings in affected patients was observed in rats administered the two compounds. Crystal composition determination revealed the existence of melamine and uric acid in the affected kidneys, resembling human stones.
Conclusion:
Our findings suggest that uric acid plays a key role in melamine-related kidney injury in humans. Future studies should consider uric acid together with melamine when examining adverse effects in humans.
Insights
Uric acid exacerbates melamine kidney injury in rats. Combining melamine and uric acid (from potassium oxonate) caused significant renal damage and mortality, suggesting uric acid is key in human melamine toxicity.
Area of Science:
- Toxicology
- Nephrology
- Biochemistry
Background:
- Melamine is a chemical contaminant that can cause kidney damage.
- Uric acid is a common component of human kidney stones.
- Hyperuricemia can be induced using uricase inhibitors like potassium oxonate.
Purpose of the Study:
- To investigate if uric acid exacerbates melamine-induced nephrotoxicity.
- To evaluate melamine and uric acid interactions in a rat model.
Main Methods:
- Rats were administered varying doses of melamine and potassium oxonate (to induce hyperuricemia) for three days.
- Kidney injury was assessed via biochemical markers, histomorphology, and lipid peroxidation.
- Kidney crystals were analyzed for composition.
Main Results:
- Minimal toxicity was observed with melamine or potassium oxonate alone.
- Combined administration, especially at higher doses (e.g., 400+600 mg/kg), led to significant renal damage and high mortality rates.
- Kidney crystals containing both melamine and uric acid were found, similar to human renal stones.
Conclusions:
- Uric acid plays a critical role in melamine-related kidney injury.
- Future research on melamine's adverse effects in humans should account for uric acid levels.
More Related Videos
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
07:45Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis
Published on: February 9, 2021
Related Concept Videos
Nephrotic Syndrome I : Introduction
Chronic Kidney Disease II: Clinical Manifestations
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Urinary Tract Calculi III: Medical Management
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Chronic Kidney Disease III: Interprofessional Care